Kathryn J. Ruddy

20.9k total citations · 1 hit paper
324 papers, 8.7k citations indexed

About

Kathryn J. Ruddy is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Kathryn J. Ruddy has authored 324 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 184 papers in Oncology, 70 papers in Public Health, Environmental and Occupational Health and 59 papers in Genetics. Recurrent topics in Kathryn J. Ruddy's work include Cancer survivorship and care (63 papers), Breast Cancer Treatment Studies (53 papers) and BRCA gene mutations in cancer (47 papers). Kathryn J. Ruddy is often cited by papers focused on Cancer survivorship and care (63 papers), Breast Cancer Treatment Studies (53 papers) and BRCA gene mutations in cancer (47 papers). Kathryn J. Ruddy collaborates with scholars based in United States, Canada and United Kingdom. Kathryn J. Ruddy's co-authors include Ann H. Partridge, Fátima Cardoso, Javier Cortés, Nadia Harbeck, Janice Tsang, Nehmat Houssami, Frédérique Penault‐Llorca, Michael Gnant, Philip Poortmans and Lidia Schapira and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Kathryn J. Ruddy

289 papers receiving 8.6k citations

Hit Papers

align trajectories

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathryn J. Ruddy United States	44	4.1k	1.7k	1.6k	1.4k	1.3k	324	8.7k
Lori M. Minasian United States	49	3.6k 0.9×	1.5k 0.9×	1.2k 0.8×	2.0k 1.4×	673 0.5×	201	9.9k
Lucia Del Mastro Italy	48	5.3k 1.3×	1.8k 1.1×	2.5k 1.5×	1.2k 0.8×	1.6k 1.2×	332	8.7k
Vivianne C. G. Tjan‐Heijnen Netherlands	51	5.4k 1.3×	847 0.5×	3.5k 2.2×	1.7k 1.2×	1.1k 0.9×	289	10.7k
Kamila Czene Sweden	44	3.2k 0.8×	681 0.4×	2.0k 1.2×	1.3k 0.9×	1.6k 1.3×	261	7.1k
Nicholas Pavlidis Greece	60	8.7k 2.1×	977 0.6×	1.7k 1.0×	2.3k 1.6×	684 0.5×	324	13.2k
Christina Lacchetti United States	34	3.9k 0.9×	652 0.4×	644 0.4×	648 0.5×	627 0.5×	63	6.8k
Martin Krapcho United States	10	3.6k 0.9×	868 0.5×	1.0k 0.6×	1.3k 0.9×	589 0.5×	14	8.2k
Kent A. Griffith United States	60	4.3k 1.0×	1.9k 1.2×	2.7k 1.7×	2.0k 1.4×	600 0.5×	277	12.8k
Michael S. Simon United States	49	3.8k 0.9×	1.6k 0.9×	1.9k 1.2×	1.2k 0.8×	2.0k 1.6×	261	7.7k
Charles L. Shapiro United States	60	7.3k 1.8×	808 0.5×	2.9k 1.8×	3.8k 2.6×	1.0k 0.8×	233	13.1k

Countries citing papers authored by Kathryn J. Ruddy

Since Specialization

Citations

This map shows the geographic impact of Kathryn J. Ruddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn J. Ruddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn J. Ruddy more than expected).

Fields of papers citing papers by Kathryn J. Ruddy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn J. Ruddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn J. Ruddy. The network helps show where Kathryn J. Ruddy may publish in the future.

Co-authorship network of co-authors of Kathryn J. Ruddy

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn J. Ruddy. A scholar is included among the top collaborators of Kathryn J. Ruddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn J. Ruddy. Kathryn J. Ruddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Sella, Tal, Shoshana M. Rosenberg, Gregory J. Kirkner, et al.. (2024). Breastfeeding experiences among young breast cancer survivors: A survey study. Cancer. 131(1). e35585–e35585. 3 indexed citations

2.

Neuman, Heather B., Caprice C. Greenberg, Lee G. Wilke, et al.. (2024). Validation of the AJCC 8th Edition Breast Cancer Prognostic Staging System in Legacy Alliance Trials (AFT-01). Annals of Surgical Oncology. 31(9). 5880–5887. 2 indexed citations

3.

Jahan, Nusrat, Nicholas Boddicker, Karthik V. Giridhar, et al.. (2024). Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience. Clinical Breast Cancer. 25(3). e211–e219.e2.

4.

Zheng, Yue, et al.. (2023). Satisfaction with Care and Attention to Age-Specific Concerns by Race and Ethnicity in a National Sample of Young Women with Breast Cancer. Journal of Adolescent and Young Adult Oncology. 13(1). 105–111.

5.

Sella, Tal, Yue Zheng, Shoshana M. Rosenberg, et al.. (2023). Extended adjuvant endocrine therapy in a longitudinal cohort of young breast cancer survivors. npj Breast Cancer. 9(1). 31–31. 3 indexed citations

6.

Lipsyc-Sharf, Marla, Esha Jain, Laura C. Collins, et al.. (2023). Genomics of ERBB2-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus Trastuzumab. JCO Precision Oncology. 7(7). e2300076–e2300076. 3 indexed citations

7.

Hertz, Daniel L., Cindy Tofthagen, Emanuela Rossi, et al.. (2023). Patient perceptions of altering chemotherapy treatment due to peripheral neuropathy. Supportive Care in Cancer. 32(1). 48–48. 6 indexed citations

8.

Yadav, Siddhartha, Lindsey R. Sangaralingham, Stephanie Payne, et al.. (2022). Surveillance mammography after treatment for male breast cancer. Breast Cancer Research and Treatment. 194(3). 693–698. 1 indexed citations

9.

Sella, Tal, Yue Zheng, Nabihah Tayob, et al.. (2022). Treatment discontinuation, patient-reported toxicities and quality-of-life by age following trastuzumab emtansine or paclitaxel/trastuzumab (ATEMPT). npj Breast Cancer. 8(1). 127–127. 5 indexed citations

10.

Choong, Grace M., S. Liddell, Roberto A. Leon Ferre, et al.. (2022). Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution study. Breast Cancer Research and Treatment. 196(1). 229–237. 9 indexed citations

11.

Vierkant, Robert A., Janet E. Olson, Joerg Herrmann, et al.. (2022). Factors Associated With Physical Activity Levels in Patients With Breast Cancer. The Oncologist. 27(10). e811–e814. 4 indexed citations

12.

Schapira, Lidia, Yue Zheng, Shari Gelber, et al.. (2021). Trajectories of fear of cancer recurrence in young breast cancer survivors. Cancer. 128(2). 335–343. 69 indexed citations

13.

Pak, Linda M., Shoshana M. Rosenberg, Kathryn J. Ruddy, et al.. (2020). Tumor phenotype and concordance in synchronous bilateral breast cancer in young women. Breast Cancer Research and Treatment. 186(3). 815–821. 5 indexed citations

14.

Ruddy, Kathryn J., Aaron S. Mansfield, Nansu Zong, et al.. (2020). Detecting and Filtering Immune-Related Adverse Events Signal Based on Text Mining and Observational Health Data Sciences and Informatics Common Data Model: Framework Development Study. JMIR Medical Informatics. 8(6). e17353–e17353. 8 indexed citations

15.

Yadav, Siddhartha, Irbaz Bin Riaz, Hao Xie, et al.. (2019). Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century. Cancer. 126(1). 26–36. 90 indexed citations

16.

Poorvu, Philip D., Shari Gelber, Shoshana M. Rosenberg, et al.. (2019). Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer. Journal of Clinical Oncology. 38(7). 725–733. 48 indexed citations

17.

Yu, Yue, et al.. (2018). Developing A Standards-based Signal Detection and Validation Framework of Immune-related Adverse Events Using the OHDSI Common Data Model.. AMIA. 1 indexed citations

18.

Morrison, Eleshia J. P., Paul J. Novotny, Jeff A. Sloan, et al.. (2017). Emotional Problems, Quality of Life, and Symptom Burden in Patients With Lung Cancer. Clinical Lung Cancer. 18(5). 497–503. 199 indexed citations

19.

O’Sullivan, Ciara C. & Kathryn J. Ruddy. (2016). Management of Potential Long-Term Toxicities in Breast Cancer Patients. Current Breast Cancer Reports. 8(4). 183–192. 5 indexed citations

20.

Collins, Laura C., Shari Gelber, Jonathan D. Marotti, et al.. (2015). Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women. The Oncologist. 20(7). 713–718. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact